News
Rapid changes to health system spurred by COVID might be here to stay
June 9, 2020
Experts warn that the breakthroughs may not all make the health system work better or make it less expensive. That said, three trends seem likely to continue.
News
Pandemic conditions can complicate care of patients with PAH
June 9, 2020
Guidance emphasizes need for individual risk assessment and use of telemedicine when possible.
News
Aspirin and warfarin together leads to increased bleeding without reducing thrombotic events
June 9, 2020
In patients taking warfarin for atrial fibrillation (AFib) or venous thromboembolism (VTE), how often is aspirin used without a clear indication, and what are the clinical outcomes for these patients?
News
Catheter ablation of AFib improves quality of life more than medications do
June 8, 2020
Does catheter ablation of atrial fibrillation (AFib) improve quality of life (QOL) compared to medication therapy?
News
#WhiteCoats4BlackLives: A ‘platform for good’
June 5, 2020
Sporadic protests – with participants in scrubs or white coats kneeling for 8 minutes and 46 seconds in memory of George Floyd – have quickly grown into organized, ongoing, large-scale events at hospitals, medical campuses, and city centers.
News
QI initiative can decrease unnecessary IV treatment of asymptomatic hypertension
June 5, 2020
How common is treatment of asymptomatic hypertension in the hospital with IV medications and what is the impact of a quality improvement initiative to reduce use?
News
COVID-19-related inflammatory condition more common in black children in small study
June 5, 2020
It appears any increased risk in black children for developing the multisystem inflammatory syndrome linked to COVID-19 is likely due to social disparities.
News
COVID-19 neurologic effects: Does the virus directly attack the brain?
June 5, 2020
There are neurologic sequelae of COVID-19. “We need to be alert to these, and to try to understand the potential long-term consequences.”
News
FDA approves new antibiotic for HABP/VABP treatment
June 5, 2020
Recarbrio was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections.
News
Lancet, NEJM retract studies on hydroxychloroquine for COVID-19
June 4, 2020
The Lancet issued a retraction of an influential study of hydroxychloroquine use in COVID-19 patients. Hours later, NEJM retracted a second study from the same group.